EDS  Exceed Company Ltd.

Exchange

NASDAQ

Sector

Finance

Industry

Business Services

Market Cap.

54.67M

Vuru Grade

48.19/100

Current Price

$2.00
+0 (+0%)

Growth Price

$4.62
Undervalued by 131.03%

Stability Price

$5.30
Undervalued by 164.77%

Company Metrics

  • P/E 3.07
  • P/S 0.19
  • P/B 0.15
  • EPS 1
  • Cash ROIC 7.56%
  • Cash Ratio 3.64
  • Dividend 0 / 0%
  • Avg. Vol. 10,119.00
  • Shares 33.08M
  • Market Cap. 54.67M

Company Description

Exceed Company Ltd. engages in the design, development, and wholesale of footwear, apparel, and accessories for sports and leisurewear consumers in China. The company offers running, leisure, basketball, skateboarding, canvas, tennis, and outdoor footwear; various apparel products, including sports tops, pants, jackets, track suits, and coats; and accessories, such as bags, socks, hats, and caps. ... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Record growth for Hypnos as sales exceed £60m
Cabinet Maker - 8 hours ago
Record growth for Hypnos as sales exceed £60m ... According to its latest filed accounts for the year ended 25 June 2016, overall sales for its Hypnos Limited and Hypnos Contract Beds Limited businesses rose by 32% to more than £62m on last year ...
The Sun losses exceed £60m as ad slump and hacking charges take toll
The Guardian - Jan 5, 2017
Its parent company, Times Newspapers Limited, said there was a “solid” performance in print sales income, including the first cover price increase in two years last April, and digital subscriptions, which grew to 182,000.
Chinese Phonemaker Xiaomi Aims to Exceed $14 Billion Sales
Bloomberg - Jan 12, 2017
Xiaomi secured $1.1 billion in 2014 from investors including GIC Pte., All-Stars Investment Ltd. and DST. The company is now counting on India to provide the next leg of growth: sales there surpassed $1 billion in 2016. Apart from phones, the company ...
Japan's Takeda expects annual sales of Ariad's lung cancer drug to exceed ...
Reuters - Jan 10, 2017
TOKYO Jan 10 Japan's Takeda Pharmaceutical Co Ltd expects annual sales from new lung cancer drug brigatinib, added to its portfolio with the acquisition of Ariad Pharmaceuticals Inc, will exceed $1 billion, the Japanese company's CEO said on Tuesday.
Takeda to Acquire ARIAD Pharmaceuticals, Inc. - Business Wire (press release)
May Sparks Biggest Gains in 8 Years For Cable
MarketPulse (blog) - 3 hours ago
OANDA Europe Limited is a company registered in England number 7110087 limited by shares with its registered office at Tower 42, Floor 9a, 25 Old Broad St, London EC2N 1HQ and is authorised and regulated by the Financial Conduct Authority, No: ...
Fed's Brainard Says CB Would React to Higher Inflation Sparked by Fiscal Changes
MarketPulse (blog) - 3 hours ago
OANDA Europe Limited is a company registered in England number 7110087 limited by shares with its registered office at Tower 42, Floor 9a, 25 Old Broad St, London EC2N 1HQ and is authorised and regulated by the Financial Conduct Authority, No: ...
IEA President Says Oil Prices Facing Downward Pressure Despite OPEC
MarketPulse (blog) - 3 hours ago
The oil cartel's production cut last year gave a boost to prices as it limited supply, but Birol expects other countries - most notably the U.S.
Trump Comments Send Dollar Lower
MarketPulse (blog) - 9 hours ago
OANDA Europe Limited is a company registered in England number 7110087 limited by shares with its registered office at Tower 42, Floor 9a, 25 Old Broad St, London EC2N 1HQ and is authorised and regulated by the Financial Conduct Authority, No: ...
FINAL FANTASY XV SHIPMENT AND DIGITAL SALES EXCEED SIX MILLION UNITS
Gamasutra - Jan 10, 2017
Those who download the Holiday Pack (Free Version) or Holiday Pack+ will also gain access to the “Moogle Chocobo Carnival,” a special in-game event that brings an exciting festival to the whole city of Altissia, starting on Tuesday, January 24 th for a ...
May to Detail Out 12 Point Brexit Plan
MarketPulse (blog) - 9 hours ago
OANDA Europe Limited is a company registered in England number 7110087 limited by shares with its registered office at Tower 42, Floor 9a, 25 Old Broad St, London EC2N 1HQ and is authorised and regulated by the Financial Conduct Authority, No: ...